Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Christoph Antz

Tracked across 5 events · 33 articles · First seen Jul 06, 2026 · Last active Jul 29, 2026

Sentiment
5
Attention
2
Events
5
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Impact: As CEO and Co-Founder of VERAXA, Christoph Antz announced the collaboration and expressed optimism about AI integration in drug development.
Jul 13, 2026 · 7 articles
2 10
Business
Impact: CEO Christoph Antz is quoted providing strategic direction and confidence in the BiTAC platform.
Jul 06, 2026 · 7 articles
2 0
Business
Impact: Christoph Antz, CEO and Co-Founder, commented on the patent developments, emphasizing the importance of IP strategy for the company.
Jul 29, 2026 · 6 articles
1 5
Business
Impact: As CEO and Co-Founder, Antz is listed as a contact but not directly involved in the EGM proceedings.
Jul 24, 2026 · 6 articles
2 0
Regulatory
Impact: Christoph Antz is CEO of VERAXA, but is not directly quoted or involved in this specific announcement.
Jul 20, 2026 · 7 articles
VERAXA Biotech AG ceo Christoph Antz Christoph Antz is the Chief Executive Officer and Co-Founder of VERAXA Biotech A
VERAXA Biotech AG Christoph Antz
ERGEN INTELLIGENCE
Track Christoph Antz live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.